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Background: Hypothalamic pathology is a well-documented feature of Huntington’s 
disease (HD) and is believed to contribute to circadian rhythm and habitual sleep 
disturbances. Currently, no therapies exist to combat hypothalamic changes, nor circadian 
rhythm and habitual sleep disturbances in HD. 
Objective: To evaluate the effects of multidisciplinary rehabilitation on hypothalamic 
volume, brain-derived neurotrophic factor (BDNF), circadian rhythm and habitual sleep in 
individuals with preclinical HD. 
Methods: Eighteen individuals with HD (ten premanifest and eight prodromal) 
undertook a nine-month multidisciplinary rehabilitation intervention (intervention group), 
which included exercise, cognitive and dual task training and social events, and were 
compared to a community sample of eleven individuals with premanifest HD receiving no 
intervention (control group). Hypothalamic volume, serum BDNF, salivary cortisol and 
melatonin concentrations, subjective sleep quality, daytime somnolence, habitual sleep-wake 
patterns, stress and anxiety and depression symptomatology were evaluated. 
Results: Hypothalamus grey matter volume loss was significantly attenuated in the 
intervention group compared to the control group after controlling for age, gender, Unified 
Huntington’s Disease Rating Scale-Total Motor Score and number of cytosine-adenine-
guanine repeats. Serum BDNF levels were maintained in the intervention group, but 
decreased in the control group following the study period. Both groups exhibited decreases in 
cortisol and melatonin concentrations. No changes were observed in sleep or mood outcomes. 
Conclusions: This exploratory study provides evidence that multidisciplinary 
rehabilitation can reduce hypothalamic volume loss and maintain peripheral BDNF levels in 
individuals with preclinical HD but may not impact on circadian rhythm. Larger, randomised 
controlled trials are required to confirm these findings. 
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Hypothalamic pathology, including grey matter volume loss and microglial activation, 
has been reported as early as a decade prior to clinical manifestation of Huntington’s disease 
(HD) (Kremer et al., 1991;  Petersén et al., 2005;  Aziz et al., 2008;  Politis et al., 2008;  
Gabery et al., 2010;  Soneson et al., 2010). Degeneration within the hypothalamus, 
particularly the suprachiasmatic nucleus (SCN), which is responsible for controlling the 
circadian rhythms, is believed to underpin sleep and circadian deficits in individuals with HD 
(Moore, 1995;  Morton et al., 2005;  Saper et al., 2005;  Aziz et al., 2010;  Bartlett et al., 
2016). 
Disturbances in circadian rhythmicity and sleep are documented in HD mouse 
models, as well as in humans (Kudo et al., 2011;  Morton, 2013;  Lazar et al., 2015). 
Circadian changes appear to commence during the premanifest stages of HD and worsen as 
the course of the disease lengthens. In particular, early changes in the circadian regulation of 
cortisol and melatonin and a delay of the habitual sleep timing have been noted in individuals 
with premanifest HD (Aziz et al., 2009a;  Aziz et al., 2009b;  Aziz et al., 2010;  van Duijn et 
al., 2010;  Kalliolia et al., 2014). Furthermore, studies in the R6/2 HD mouse model have 
revealed altered night-day activity ratios, which has also been reported in individuals with 
manifest HD (Morton et al., 2005). These alterations in circadian rhythm could potentially 
mediate sleep deficits that have been reported in HD (Lazar et al., 2015). Lazar et al. (2015) 
reported early changes in sleep architecture, particularly increased sleep fragmentation, prior 
to clinical onset of HD. Given that the onset of circadian rhythm and disturbances occur 
during the premanifest phase of HD, early treatments aimed at reducing or ameliorating 
degeneration of the hypothalamus or targeting circadian rhythm and habitual sleep 
disturbances are warranted. 
Evidence from animal models and other clinical populations suggests that 
interventions comprising exercise have the potential to improve circadian rhythm and sleep 
outcomes (Cuesta et al., 2014;  Nascimento et al., 2014). It is not known, however, if these 
improvements are mediated by changes in the hypothalamus. In patients with HD, our team 
has previously shown that nine months of multidisciplinary rehabilitation, involving exercise 
and cognitive training, enhances brain volume in the striatum and prefrontal cortex and 
improves cognition and motor function (Thompson et al., 2013;  Cruickshank et al., 2015). 
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these areas is not yet known. A possibility is that multidisciplinary rehabilitation exerts its 
effects on the brain by upregulating levels of brain derived neurotrophic factor (BDNF), since 
BDNF is vital for neurogenesis following environmental enrichment in animal models (Rossi 
et al., 2006). This is supported by studies in HD mouse models, in which BDNF levels were 
rescued following environmental enrichment, as well as by research into other 
neurodegenerative and clinical populations, whereby increases in BDNF levels have been 
reported following intervention paradigms comprising an exercise component (Cotman and 
Berchtold, 2002;  Spires et al., 2004;  Frazzitta et al., 2014). 
In the present study, we aimed to examine the effects of a nine-month 
multidisciplinary rehabilitation intervention on BDNF levels, hypothalamic volume, circadian 
rhythm, and habitual sleep outcomes in individuals with premanifest HD. In line with 
findings suggesting an increase in BDNF levels following multimodal exercise paradigms 
(Nascimento et al., 2014) and with the proposed role of the hypothalamus in circadian rhythm 
disturbances in HD (Aziz et al., 2008;  Bartlett et al., 2016), we hypothesised that 
multidisciplinary rehabilitation would increase BDNF levels, attenuate hypothalamic volume 
loss and improve circadian rhythm and habitual sleep outcomes in individuals with 
premanifest HD. 
Materials and Methods 
Study Design 
The present investigation was a controlled, non-randomised, non-blinded exploratory 
study. This study design was adopted due to the rarity of the disease (9.7 per 100,000 in 
Australia (Rawlins et al., 2016)), the widespread distribution of individuals across Australia 
and the proof-of-concept nature of the study. The aim was to investigate the effects of nine 
months of multidisciplinary rehabilitation on hypothalamic volume as the primary outcome 
and blood-based BDNF, markers of circadian rhythm and habitual sleep-wake outcomes as 
secondary outcomes in individuals with preclinical HD. Subjective sleep quality, daytime 
somnolence and stress, anxiety and depression symptomatology were also examined. Study 
participants were allocated to one of two groups: one receiving nine months of 
multidisciplinary rehabilitation (intervention group, n = 18) or a group receiving no 
intervention (control group, n = 11). All outcomes were measured at baseline and following 
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work, which showed changes in grey matter volume after nine months of multidisciplinary 
rehabilitation (Thompson et al., 2013;  Cruickshank et al., 2015).  
Study Approval and Patient Consent 
All aspects of the study were conducted in accordance with the declaration of 
Helsinki. Ethical approval for study procedures was granted by the North Metropolitan Area 
Mental Health Service (2009_16), Edith Cowan University (13145), Monash University 
(CF15/117- 2015000058) and Deakin University (2015-052) human research ethics 
committees at Perth and Melbourne study sites. All participants provided written informed 
consent. The study was registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12618001717246). 
Participants 
Twenty-seven premanifest (prior to onset of motor signs) HD and eight prodromal 
(slight, but no overt, motor signs) HD individuals were recruited in Perth and Melbourne 
through ENROLL-HD, existing study databases, clinicians and HD community organisations. 
Inclusion criteria were as follows: 1) a cytosine-adenine-guanine (CAG) repeat length of > 
39; 2) a Unified Huntington’s Disease Rating Scale (UHDRS) Diagnostic Confidence Level 
(DCL) of ≤ 2; and 3) a UHDRS Total Motor Score (UHDRS-TMS) of < 5 for premanifest or 
> 5 for prodromal HD (Reilmann et al., 2014). Exclusion criteria were as follows: 1) 
concomitant neurological, cardiovascular, musculoskeletal, endocrine or metabolic disorders, 
2) shift work, 3) recent or ongoing substance abuse, and 4) the inability to understand written 
and verbal English. 
Multidisciplinary Rehabilitation Intervention 
The multidisciplinary rehabilitation intervention was conducted in Perth (with the 
Melbourne cohort acting as an allocated control group) and was designed by an experienced 
team of exercise scientists, cognitive training, sleep and circadian rhythm specialists, 
neuroscientists and a neuropsychiatrist. Details of the intervention can be viewed in detail in 
supplementary files. Briefly, the intervention was fully supervised by clinical exercise 
physiologists and cognitive training specialists and consisted of autoregulated periodised 
aerobic and resistance training, computerised cognitive training, dual-task training, bilingual 
exercises, healthy lifestyle guidance and social activities. Periodised aerobic and resistance 
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and comprised resistance, endurance and high-intensity interval training (Jimenez and Paz, 
2011;  Harries et al., 2015). Supervised computerised cognitive training was informed by a 
meta-analysis and by previous investigations (Lampit et al., 2014a;  2014b;  2014c;  2015). 
Computerised cognitive training was performed three times weekly for one hour using 
NeuroNation (Synaptikon, Berlin, Germany) and Captain’s Log MindPower Builder 
(BrainTrain Inc., Richmond, VA) software (30 minutes each program) and targeted working 
memory, visual scanning, processing speed, attention, planning, problem solving and task 
switching cognitive domains. Dual-task training was performed once weekly for one hour 
and consisted of combined aerobic and resistance training and cognitive exercises (Yogev-
Seligmann et al., 2012;  Fritz et al., 2015). Social events were organised every twelve weeks 
and intervention sessions were conducted in small groups (2-8 participants per session) to 
encourage social engagement, which has been shown to facilitate adherence to exercise 
programs in older adults (Thurston and Green, 2004). 
Training Adherence and Compliance  
Adherence to training sessions and compliance to prescribed exercises were 
monitored and recorded using a training diary by the exercise physiologists delivering the 
intervention. The intensity of exercises was monitored using cognitive training software 
(computerised cognitive training), heart rate monitors (aerobic exercise), the Borg Rating of 
Perceived Exertion (RPE) scale (Borg, 1982) (both aerobic and resistance exercise) and a 
visual analogue scale (dual tasking exercises). The volume of aerobic training was monitored 
using the duration and intensity of exercise. Resistance training volume was calculated using 
the number of sets and repetitions of exercise performed. An autoregulation periodization 
model was used to modulate training based on patient motivation and readiness to train in 
consultation with exercise physiologists (Mann et al., 2010;  Zourdos et al., 2016).  
MRI Data Acquisition and Pre-processing 
T1-weighted structural images of the brain were obtained from each participant in 
Perth and Melbourne using a GE Healthcare Discovery or a Siemens Skyra 3T MRI scanner, 
respectively. In Perth, images were acquired with a 24-channel head coil using an IR-SPGR 
sequence (TA = 9 m 59 s, TR = 3 s, TE = Min, TI = 400 ms, flip angle = 11˚, field of view = 
256 mm, image matrix = 256 x 256, 1 mm3 isotropic voxels). In Melbourne, acquisition took 
place with a 32-channel head coil and an MP-RAGE sequence (TA = 9 m 14 s, TR = 2.3 s, 
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256). Images were acquired consistently across both sites according to the Alzheimer’s 
Disease Neuroimaging Initiative protocols for multi-site imaging (Jack et al., 2008). Three 
participants also underwent additional scans at both sites to ensure consistency (Bartlett et al., 
2019). Image pre-processing was conducted according to a longitudinal pipeline (Eshaghi et 
al., 2014) implemented in SPM12 (http://www.fil.ion.ucl.ac.uk/spm) running on Matlab 
R2015a (Mathworks, Natick, Massachusetts; see Supplementary Data). A hypothalamus 
mask from the WFU Pick Atlas (http://fmri.wfubmc.edu/software/pickatlas) was used 
(dilated by 3mm) to restrict analysis to this area (Breen et al., 2016). Results are reported in 
MNI space with a voxel size of 1 mm isotropic and displayed on the ch256 template.   
Blood-based BDNF Analysis 
Blood was collected from participants via venepuncture into serum gel separator tubes 
(Vacuette, Greiner Bio-one) one hour following awakening. Blood was collected in the 
morning at the same time (± 60 minutes) prior to and following the study period to minimise 
the potential effects of circadian variation on BDNF levels (Piccinni et al., 2008). The blood 
was left to clot for at least 30 minutes and then centrifuged at 1800 x g for 10 minutes. Serum 
was then stored at -80ºC until analysis in duplicate using BDNF Emax ELISA kits (Promega, 
Madison, WI) according to the manufacturer’s instructions (Ciammola et al., 2007). 
Salivary Cortisol and Melatonin Analysis 
Saliva samples were collected by participants in their own homes on two consecutive 
days prior to and following the nine-month study period. Participants were instructed to 
passively drool into four separate polypropylene collection tubes (SSI Bio) at four time points 
in the morning at 15, 30, 45 and 60 minutes following awakening for morning cortisol 
analysis and at four time points across the evening at one hour intervals from two hours 
before their usual bedtime (T1) until one hour after their usual bedtime (T4) for melatonin 
analysis (Voultsios et al., 1997;  van Duijn et al., 2010). To avoid contamination of samples, 
participants were instructed to refrain from consuming alcohol 12 hours prior and to avoid 
eating, drinking (with the exception of water) and brushing their teeth within the hour prior to 
sampling (van Duijn et al., 2010). For melatonin sampling, participants were also instructed 
to wear sunglasses and to remain in a dimly lit room during the three-hour sampling 
timeframe to avoid suppressive effects of light on melatonin rise (Voultsios et al., 1997). 
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samples were stored at -80ºC until analysis in duplicate using salivary cortisol and melatonin 
ELISA kits (Salimetrics, USA) according to the manufacturer’s instructions. 
Subjective Sleep Assessments 
Sleep questionnaires were used to measure habitual sleep/wake timing, sleep quality 
and daytime somnolence prior to and following the nine-month study period (Aziz et al., 
2010;  Lazar et al., 2015). Habitual sleep wake timing was measured using the Consensus 
Sleep Diary (CSD) (Carney et al., 2012), which was devised to standardise the measurement 
of habitual sleep parameters. Subjective sleep quality was assessed using the Pittsburgh Sleep 
Quality Index (PSQI) (Buysse et al., 1989). The PSQI comprises seven components relating 
to subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleep medication and daytime dysfunction. Scores are summated to 
provide a global PSQI score, of which a score of greater than five indicates poor sleep 
quality. Daytime somnolence was assessed using the Epworth Sleepiness Scale, with a score 
of greater than 10 indicating excessive daytime sleepiness (Johns, 1991). The PSQI and 
Epworth Sleepiness Scale have been used previously in HD research (Aziz et al., 2010;  
Lazar et al., 2015). 
Mood Measures 
Psychological stress over the previous month was measured using the 14-item 
Perceived Stress Scale (Cohen et al., 1983) and anxiety and depression symptomatology were 
measured using the Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 
1983). Both scales are deemed valid for use in HD research (De Souza et al., 2010;  Downing 
et al., 2011). 
Statistical Analysis 
Data from the premanifest and prodromal HD intervention groups were combined. 
This was based on preliminary analyses that showed no differences in neuroimaging or 
secondary outcome measures at baseline between the premanifest and prodromal intervention 
groups (data on groups separated can be viewed in supplementary files). Data from the 
combined intervention group was compared to the premanifest HD community sample. To 
control for clinical differences, UHDRS-TMS was included as a covariate in analyses. 
Missing saliva sampling data points (n = 5 of 504, 0.99%) were interpolated using the 
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samples to avoid removing the participant from analyses and to maintain sample size (van 
Duijn et al., 2010). Area under the curve with respect to ground (AUCG) was calculated using 
the trapezoid rule for morning cortisol and evening melatonin output (van Duijn et al., 2010;  
Dijk et al., 2012). 
Shapiro-Wilk tests were used to test normality assumptions. Baseline group 
differences were assessed using independent t-tests and Mann-Whitney U tests. Within-group 
and between-group differences were assessed using a mixed analysis of variance (ANOVA), 
with age, gender, UHDRS-TMS and CAG repeat included as covariates. Two-tailed 
statistical significance was interpreted at an a priori α = 0.05. 
We then assessed voxel-wise differences in hypothalamic volume change between 
baseline and nine-month follow-up between intervention and control groups using grey 
matter Jacobian change images from each respective group. In addition to differences 
between the control and the intervention group as a whole, we also evaluated differences 
between the control group and the intervention group split into premanifest and prodromal 
subgroups (see supplementary data). A general linear model was used to estimate voxel-wise 
hypothalamic volume change between baseline and the 9-month follow-up (represented in 
grey matter Jacobian change images) across the three groups. Individual regressors were 
included for each group. Contrasts comparing controls vs. intervention premanifest, controls 
vs. intervention prodromal and controls vs. all intervention preclinical participants were 
evaluated with independent samples t-tests. We also tested for within group volume change 
over time in areas revealing a group difference. Using the same grey matter Jacobian change 
images, we also investigated group differences in the association between change in 
hypothalamic volume and change in cortisol and/or melatonin output in the intervention 
compared to the control group, using a categorical by continuous covariate interaction model 
(see supplementary data for details of this model). Sex and age were included as covariates of 
no interest in all analyses. The MarsBaR tool box (Brett et al., 2002) was used to extract 
parameter estimates from relevant contrasts (the average of all significant voxels in the 
relevant contrast) to generate plots illustrating the results from the VBM analysis. Given the 
exploratory nature of this study and our a priori interest in the hypothalamus, all results are 
reported at α = 0.05, uncorrected. Statistical analyses were carried out using STATA 
(StataCorp., College Station, TX) and the R statistical programming language (R Core 
Development Team, 2014). Cohen’s d effect sizes were considered small at 0.2, medium at 














Demographic and Clinical Characteristics 
Two participants withdrew from the study prior to baseline testing and four withdrew 
following baseline testing. Analyses were conducted on data obtained from ten premanifest 
HD and eight prodromal HD participants in the intervention group and 11 premanifest HD 
participants in the allocated control group. 
Demographic and clinical characteristics for the intervention and control groups are 
presented in Table 1. Age differed between the intervention group (p = 0.029) and the control 
group, but no differences were observed in gender, CAG repeat number, disease burden 
score, CAP score, UHDRS-total functional capacity (UHDRS-TFC), body mass index (BMI), 
smoking status, alcohol consumption or use of psychotropic medication between the groups 
at baseline (all p > 0.05). Higher UHDRS-TMS and diagnostic confidence level scores were 
observed in the intervention group compared to the control group (Table 1 and 
Supplementary Table 7) due to the inclusion of individuals with prodromal HD in the 
intervention group. Participants displayed high adherence (attended 78 out of a possible 90 
sessions, 87%) and compliance (complied to 77 out of a possible 90 sessions, 85%) to 
training sessions throughout the intervention.  
 
Table 1. Demographic and clinical characteristics of the HD intervention group and 









Age, mean ± SD 40.89 ± 11.73 50.55 ± 9.49 0.029* 
Male, n (%) 6 (33) 4 (36) 0.868 
Clinical Characteristics 
CAGn, mean ± SD 43.67 ± 3.28 41.91 ± 2.02 0.123 
DCL, mean ± SD 0.67 ± 0.84 0.00 ± 0.00 0.000* 
UHDRS-TMS, mean ± SD 7.56 ± 8.56 0.09 ± 0.30 0.000* 
UHDRS-TFC, mean ± SD 13.00 ± 0.00 13.00 ± 0.00 1.000 
Disease burden score, mean ± SD 309.52 ± 91.87 309.36 ± 61.51 0.996 
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BMI, mean ± SD 26.60 ± 3.85 25.29 ± 1.99 0.303 
Smoker, n (%) 6 (33) 1 (9) 0.172 
High alcohol consumption, n (%) 2 (11) 0 (0) 0.394 
Psychotropic medication, n (%) 2 (11) 3 (27) 0.264 
*Values are significant at p ≤ 0.05. 
CAGn= cytosine-adenine-guanine repeat number; DCL= diagnostic confidence level; UHDRS-TMS= 
Unified Huntington’s Disease Rating Scale- Total Motor Score; UHDRS-TFC= UHDRS-Total 
Functional Capacity; CAPs= CAG-age product score; BMI= body mass index. 
 
Hypothalamic Volume 
Voxel-wise analysis revealed significantly less right hypothalamic grey matter 
volume loss in the intervention group compared to the control group following the nine-
month study period (Table 2 and Figure 1A). The differences corresponded to a large effect 
size (Cohen’s d = 1.1, computed from associated parameter estimates) and suggest that 
multidisciplinary rehabilitation slows the rate of grey matter loss in the right hypothalamus. 
This result was replicated when the intervention group was divided into premanifest and 
prodromal sub-groups (see Supplementary Table 8). Importantly, the volume loss over the 
nine-month period in the right hypothalamus in the control group was statistically significant 
(see Table 2), whereas there was no statistically significant volume loss in the intervention 
group. 
 
Table 2. Voxel-based morphometry analysis of the hypothalamus and its relationship 








x y z 
Hypothalamus Volume        
Volume loss in control group R 311 3.39 0.001* 8 3 -13 
Greater volume loss in control group (n=12) vs 
intervention group (n=17) 
R 321 2.90 0.004* 5 2 -7 
Cortisol and Melatonin        
Group x Cortisol Interaction Effect        














Group x Melatonin Interaction Effect        
Control group (n=10) vs. intervention group 
(n=17) 
R 86 2.36 0.014* 8 -2 -14 
Results are significant at p < 0.05. 
k = No. of voxels; MNI = Montreal Neurological Institute; R = right. 
 
 
Figure 1. Effects of nine months of multidisciplinary therapy on hypothalamic grey matter 
(GM) volume as revealed by VBM analysis. (A) Group effect on GM volume and bar graphs 
illustrating the effect. Values in the bar graphs correspond to the mean volume change in each 
group (after averaging across voxels in each participant). (B) Group by cortisol output change 
interaction effect on GM volume (control group outliers excluded from the analysis are in 
cross-hatching). (C) Group by melatonin output change interaction effect on GM volume. 
Scatterplots in (B) and (C) illustrate the respective interaction effects (a.u., arbitrary units). 
Heat maps correspond to T-scores thresholded at p < 0.05, uncorrected. The maps are 
displayed at x = ~8 (MNI) and are scaled to the peak T-score for the relevant analysis (see 
Table 2). 
 
Serum BDNF Analysis 
A within × between group interaction (p = 0.030; Table 3 and Supplementary Table 9) 
was observed for serum BDNF. This was denoted by a decrease in serum BDNF levels in the 
control group (p = 0.008), while serum BDNF levels were maintained in the intervention 
group over the study period (p = 0.869), suggesting that multidisciplinary rehabilitation 
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Salivary Cortisol and Melatonin Analysis 
No within × between group interactions existed across the cortisol and melatonin 
measures (p = 0.355 and p = 0.809, respectively; Table 3 and Supplementary Table 9). 
However, both the intervention and control groups exhibited a decrease in cortisol and 
melatonin AUCG following the study period and the magnitude of change was not different 
between the two groups, suggesting that the multidisciplinary rehabilitation program did not 
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Table 3. Mean serum BDNF and salivary cortisol and melatonin concentrations, subjective sleep outcomes and affective 
symptomatology outcomes in the preclinical HD intervention and control groups 
Outcome 
Intervention Group (n=18) Control Group (n=11) Within × Between 
Groups Interaction 
Within Group Between Groups 
 
Baseline Follow-Up Baseline Follow-Up p-Value Partial η
2
 p-Value Partial η
2
 p-Value Partial η
2
 
Serum BDNF (pg/mL) 26920.8 ± 1613.4 27227.4 ± 1073.7 30126.5 ± 2041.1 23358.9 ± 1358.3 0.030* 0.188 0.933 0.000 0.846 0.002 
Cortisol  (nmol/L)           
Awakening (hh:mm) 6:06 ± 00:14 6:02 ± 00:13 6:05 ± 00:18 7:00 ± 00:17 0.020* 0.213 0.774 0.004 0.157 0.085 
Time of sample relative to 
awakening: 
    0.328 0.042 0.398 0.031 0.951 0.000 
+15 mins 11.6 ± 1.0 9.1 ± 0.8 11.4 ± 1.3 8.7 ± 1.0       
+30 mins 14.6 ± 1.1 11.6 ± 0.8 13.4 ± 1.4 9.4 ± 1.0       
+45 mins 14.0 ± 0.8 12.3 ± 0.7 14.1 ± 1.1 11.0 ± 0.9       
+60 mins 12.3 ± 0.9 11.2 ± 0.8 12.6 ± 1.2 9.4 ± 1.0       
AUCG 40.5 ± 2.4 34.0 ± 1.8 39.5 ± 3.1 29.4 ± 2.2 0.355 0.037 0.714 0.006 0.347 0.039 
Melatonin (pg/mL)           
Bedtime (hh:mm) 22:00 ± 00:12 21:58 ± 00:12 22:12 ± 00:15 21:54 ± 00:15 0.281 0.053 0.013* 0.247 0.825 0.002 
Time of sample relative to 
bedtime: 
    0.719 0.006 0.326 0.042 0.346 0.039 
-2 hrs 13.9 ± 2.3 8.9 ± 2.8 11.9 ± 2.9 7.2 ± 3.6       
-1 hr 15.6 ± 2.8 8.6 ± 1.9 13.1 ± 3.5 6.6 ± 2.4       
+0 hrs 21.2 ± 3.0 12.8 ± 2.5 15.7 ± 3.8 8.5 ± 3.1       
+1 hr 23.1 ± 3.6 13.5 ± 2.8 16.4 ± 4.6 9.4 ± 3.5       
AUCG 53.5 ± 7.6 32.6 ± 6.6 42.0 ± 9.6 23.5 ± 8.4 0.809 0.003 0.437 0.027 0.353 0.038 
CSD           
Total time in bed (min) 423.0 ± 12.9 424.1 ± 20.1 433.5 ± 16.3 496.8 ± 25.2 0.025* 0.228 0.874 0.001 0.109 0.124 
Total sleep time (min) 378.6 ± 14.4 379.0 ± 15.2 389.4 ± 18.0 453.2 ± 19.1 0.008* 0.303 0.837 0.002 0.067 0.158 
Sleep onset latency (min) 24.3 ± 6.0 22.6 ± 5.2 8.0 ± 7.5 10.8 ± 6.5 0.697 0.008 0.290 0.056 0.066 0.159 
Wake after sleep onset 
(min) 
18.2 ± 6.4 11.8 ± 4.8 7.0 ± 8.1 5.3 ± 6.0 0.667 0.009 0.644 0.011 0.262 0.063 
Number of awakenings 1.6 ± 0.4 1.4 ± 0.4 0.5 ± 0.5 1.3 ± 0.5 0.218 0.075 0.276 0.059 0.252 0.065 
Sleep efficiency (%) 89.8 ± 3 89.9 ± 2.7 90.2 ± 3.8 92.2 ± 3.4 0.610 0.013 0.823 0.003 0.759 0.005 
Restorative quality of 
sleep 
3.5 ± 0.3 3.5 ± 0.2 3.7 ± 0.3 4.0 ± 0.3 0.420 0.035 0.706 0.008 0.468 0.028 
PSQI Global Score 5.8 ± 0.8 5.4 ± 0.8 5.2 ± 1.0 4.9 ± 1.0 0.925 0.000 0.633 0.011 0.674 0.008 
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Data are presented as mean ± standard deviation. *Values are significant at p < 0.05. Partial η
2
, 0.01, 0.06 and 0.14 are defined as small, medium and large effects, 
respectively. CSD= Consensus Sleep Diary; PSQI= Pittsburgh Sleep Quality Index; HADS= Hospital Anxiety and Depression Scale. The sleep efficiency component of the 
CSD was calculated as follows: total sleep time/total time in bed x 100. Values for the restorative quality of sleep component of the CSD range from 1-5, with lower values 
indicating worse sleep quality. Possible ranges for questionnaires are as follows: PSQI (0-21), Epworth Sleepiness Scale (0-24), Perceived Stress Scale (0-40), HADS-anxiety 
(0-21), HADS-depression (0-21).    
 
Perceived Stress Scale 18.3 ± 1.8 15.3 ± 1.9 16.6 ± 2.2 17.0 ± 2.4 0.305 0.048 0.492 0.022 0.815 0.003 
HADS total score 8.9 ± 1.3 6.3 ± 1.0 6.1 ± 1.6 6.4 ± 1.3 0.079 0.128 0.300 0.047 0.448 0.025 
Anxiety 5.8 ± 0.8 5.0 ± 0.8 4.3 ± 1.0 5.1 ± 1.0 0.155 0.086 0.655 0.009 0.587 0.013 
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Subjective Sleep Assessments 
Within × between group interactions were observed for the time of awakening (p = 
0.020), total time in bed (p = 0.025) and total sleep time (p = 0.008; Table 3 and 
Supplementary Table 9). Sleep outcomes did not change over the nine-month study period in 
the intervention group, however the total time in bed and total sleep time increased in the 
control group (Table 3). No other differences were observed in CSD outcomes or subjective 
sleep quality (PSQI) within the intervention or control group following the nine-month study 
period.  
No other differences were observed between groups in habitual sleep/wake timing 
(CSD), subjective sleep quality (PSQI scores) or daytime somnolence (ESS scores) (Table 3 
and Supplementary Table 9). These results suggest that multidisciplinary rehabilitation did 
not alter subjective sleep quality or daytime somnolence; however, it may have the potential 
to mediate sleep/wake timing. 
Affective Symptoms 
No between × within group interactions were observed for affective symptomatology 
(Table 3 and Supplementary Table 9). Anxiety and depression scores on the HADS were 
subthreshold (< 8) for both groups, indicating no clinically meaningful anxiety 
symptomatology (Zigmond and Snaith, 1983).  
Correlative Results Between Cha ge in Hypothalamic Volume and Change in Cortisol 
and Melatonin Output 
An interaction effect was observed between group (intervention or control) and 
change in cortisol output (Table 2 and Supplementary Table 8). Parameter estimates for this 
interaction were used to generate a scatterplot with fitted lines for each group. Visual 
inspection revealed a positive slope for the relationship between change in hypothalamus 
volume and change in cortisol output in the control group. However, two potential influential 
cases were also identified, both from the control group. Regression diagnostics (Cook’s 
distance and leverage) confirmed these cases as influential. Re-running the voxel-wise 
analysis excluding these cases showed a reversal in the association between right 
hypothalamic grey matter volume loss and change in morning cortisol output in the control 
group: the association was now negative, in comparison to a flat slope for the intervention 
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parameter estimates extracted from the relevant areas, were r = -0.73, in the right, and r = -
0.57, in the left. A group by cortisol output change interaction effect on hypothalamus grey 
matter volume loss was also now observed bilaterally (right, k = 368, t = 2.54, p = 0.01, MNI 
= 7 0 -12; left, k = 29, t = 2.11, p = 0.024, MNI = -9 -8 -4; Figure 1B). 
A group by melatonin output change interaction effect on grey matter volume loss 
was observed in the right hypothalamus when comparing the intervention group to the control 
group (Figure 1C, Table 2 and Supplementary Table 8). Parameter estimates revealed the 
association between nine-month right hypothalamus grey matter volume loss and change in 
evening melatonin output was positive in the intervention group (r = 0.47) and negative in the 
control group (r = -0.51). 
 
Discussion 
Pathological disturbances in circadian rhythmicity and sleep are debilitating features 
of HD, thought to occur primarily due to degeneration within the hypothalamus. To date, no 
proven therapies exist to treat circadian rhythm and habitual sleep disturbances in individuals 
with HD. Here we show, for the first time, that multidisciplinary rehabilitation attenuated 
grey matter volume loss within the hypothalamus in individuals with preclinical HD. 
Studies by our team and others show that individuals with premanifest and prodromal 
HD have reduced grey matter volume in the hypothalamus as early as ten years prior to 
predicted clinical disease onset (Soneson et al., 2010;  Bartlett et al., 2019). Results from the 
present study suggest that multidisciplinary rehabilitation reduces hypothalamic grey matter 
volume loss, indicating that multidisciplinary rehabilitation may act to preserve the 
hypothalamus. Interestingly, this reduced volume loss occurred on the right side of the 
hypothalamus, suggesting that the intervention may have exhibited an asymmetric effect on 
the hypothalamus. However, studies with larger sample sizes are required to confirm this 
preliminary finding. To the authors’ knowledge, this is the first study to document a reduction 
in grey matter volume loss in the hypothalamus following multidisciplinary rehabilitation in 
individuals with HD. This promising finding builds upon previous work by our team, where 
multidisciplinary rehabilitation was found to increase grey matter volume in the caudate and 
dorsolateral prefrontal cortex in symptomatic HD individuals (Cruickshank et al., 2015). 
Together, these findings provide compelling evidence that adds to the growing number of 
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environmental enrichment and multidisciplinary rehabilitation, have neuroprotective effects 
capable of preserving grey matter in brain structures vulnerable to neurodegeneration in HD 
(Spires et al., 2004;  Lazic et al., 2006;  Nithianantharajah and Hannan, 2006). 
The biological mechanisms mediating the attenuation of hypothalamic volume loss 
after multidisciplinary therapy are unknown. However, it is possible that preservation of 
BDNF levels observed in the intervention group may have contributed to the attenuation of 
hypothalamic volume loss. BDNF plays a crucial role in the development, protection and 
plasticity of neurons (Bemelmans et al., 1999;  Rossi et al., 2006;  Bekinschtein et al., 2011) 
and exhibits a reduced level of expression in the hypothalamus of individuals with HD at 
post-mortem (Baldo et al., 2018). Therefore, the maintenance of serum BDNF levels as a 
result of regular exercise and cognitive training could contribute to the support and 
preservation of the hypothalamus (Bartlett et al., 2016). However, the role that BDNF plays 
in neuroplasticity is yet to be robustly confirmed. Furthermore, BDNF has been shown to 
cross the blood-brain barrier in animals (Pan et al., 1998a;  Pan et al., 1998b;  Pan and Kastin, 
1999), but the extent to which this occurs in humans has not yet been established. As such, 
our supposition that the preservation of BDNF levels following multidisciplinary 
rehabilitation may lead to maintenance of hypothalamic volume must be taken with caution.  
Attenuation of grey matter volume loss in the hypothalamus following 
multidisciplinary rehabilitation was positively associated with changes melatonin release. 
Interestingly, this finding occurred in the basal hypothalamus, a region that contains the 
suprachiasmatic nucleus. Similarly, bilateral attenuation of hypothalamic grey matter volume 
loss was also positively associated with the changes in cortisol release following the 
intervention. However, contrary to our expectations, the reduced loss of hypothalamic grey 
matter volume was not associated with improvements in habitual sleep quality following 
multidisciplinary rehabilitation, as has been reported in Parkinson’s and Alzheimer’s disease 
(Nascimento et al., 2014). We did observe reduced daytime somnolence in the group 
receiving the multidisciplinary rehabilitation intervention, which was accompanied by a 
reduction in anxiety and depression symptomatology, however the affective symptomology 
in this population was subthreshold. Given the known role of the hypothalamus in the 
modulation of sleep (Saper et al., 2005), we expected an attenuation of hypothalamic volume 
loss to positively coincide with habitual sleep outcomes. Evidence indicates that a network of 
brain structures, including the thalamus and parts of the brain stem, are responsible for 
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While multidisciplinary rehabilitation was beneficial for the hypothalamus, it may not have 
widespread positive effects on this broader network of structures necessary for the regulation 
of circadian rhythm and sleep. Therefore, future studies should assess the effects of 
multidisciplinary rehabilitation on these other structures regulating the sleep/wake cycle and 
use objective measures to assess the effects of multidisciplinary rehabilitation on sleep 
architecture rather than the subjective measures used here. 
A number of limitations need to be considered when interpreting our findings. Due to 
the rarity of the disease, the specific stage of the disease investigated and the widespread 
distribution of the individuals across Australia, a non-randomised cohort study design was 
adopted. The nature of the group allocation prevented blinding of assessors, which may have 
introduced bias. However, the objective nature of the primary and secondary outcome 
measures and the use of a statistician unaware of group allocation to conduct statistical 
analyses would have reduced the incidence of bias in the study. While this limits the 
generalisations that can be made to the wider HD community, this study provides proof-of-
concept data on the neuroprotective effects of multidisciplinary rehabilitation for the 
hypothalamus, which can be used to inform sample size estimations for future randomised 
controlled trials. Furthermore, to the authors’ knowledge, this is the first study to investigate 
the effects of multidisciplinary rehabilitation in preclinical HD. It is also the first study to use 
an autoregulated, periodized aerobic and resistance training intervention in this population 
and shows feasibility in implementing such approaches. It is important to note that brain 
imaging occurred across two study sites (Perth and Melbourne), which could potentially lead 
to between-site variation in MR images. However, a between-site consistency analysis was 
conducted, whereby three individuals underwent MRI at both locations to ensure that the 
MRI scans were obtained consistently across sites (Bartlett et al., 2019). In addition, we 
tested for within group differences in the region of the hypothalamus that showed group 
differences. We found that while there was statistically significant volume loss in the control 
group, there was no significant change in the intervention group. Consequently, even if there 
is a site effect potentially confounding the group comparison, we can nevertheless assert from 
the within group analyses that the control group exhibited volume loss in an area of the right 
hypothalamus, while the intervention group did not. This supports our intervention having a 
beneficial effect on hypothalamus volume. Finally, melatonin was only assessed at four time 
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Future studies should measure the dim light melatonin onset and its relationship with 
hypothalamic volume in individuals with preclinical HD. 
In summary, this study provides novel, preliminary evidence that multidisciplinary 
rehabilitation may reduce hypothalamic grey matter volume loss, possibly due to preservation 
of basal serum BDNF levels, and decreases daytime somnolence in individuals with 
preclinical HD. Larger randomised controlled trials are required to confirm these preliminary 
findings and to further explore the effects of multidisciplinary rehabilitation on circadian 
rhythm and habitual sleep outcomes in individuals with preclinical HD. 
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